Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
The American journal of cardiology • 1993 | View Paper
“Thus, although neither procainamide nor quinidine appear to have had a benefit on mortality, the effect of procainamide appears to be significantly worse than that of quinidine.”
The American journal of cardiology • 1991 | View Paper
“Analyses demonstrated no increase in all-cause mortality for quinidine and mexiletine over placebo, but a trend toward higher mortality with procainamide.”
The American journal of cardiology • 1991 | View Paper
“Dose response curves, plotting change in MAPD90 versus plasma drug level, showed strong linear correlation for both procainamide (p less than 0.0001) and quinidine (p less than 0.0001).”
The American journal of cardiology • 1985 | View Paper
“Clinical toxicity occasionally occurred with the increase in serum levels of quinidine and procainamide , and the dose of these drugs should be decreased when amiodarone is administered concurrently.”
“ Procainamide and quinidine both tended to prolong the effective refractory period of atrial, ventricular, and accessory pathway tissue as well as to slow antegrade and retrograde conduction in the accessory pathway.”
“Though adequate and even high drug blood levels were reached, an effective antiarrhythmic response was observed in only eight patients receiving procaine amide and in seven of those taking quinidine.”
“Considering that the therapeutic doses of procaine amide are generally larger than those of quinidine , the negative inotropic effect of the former is therapeutically more significant than that of the latter.”